Recent studies have demonstrated essential functions for KIF3, a microtubule-directed protein motor, in subcellular transport of several cancer-related proteins, including the b-catenin-cadherin(s) complex. In this study, we report identification of the protein-phosphatase Dusp26 as a novel regulator of the KIF3 motor. Here we undertake yeast two-hybrid screening and identify Kif3a, a motor subunit of the KIF3 heterotrimeric complex, as a novel Dusp26-binding protein. Co-immunoprecipitation and colocalization experiments revealed that Dusp26 associates not only with Kif3a, but also with Kap3, another subunit of the KIF3 complex. Dephosphorylation experiments in vitro and analysis using mutant forms of Dusp26 in intact cells strongly suggested that Dusp26 is recruited to the KIF3 motor mainly by interaction with Kif3a, and thereby dephosphorylates Kap3. Forced expression of Dusp26, but not its catalytically inactive mutant, promoted distribution of b-catenin/N-cadherin, an established KIF3 cargo, to cell-cell junction sites, resulting in increased cell-cell adhesiveness. We also showed that Dusp26 mRNA expression was downregulated in human glioblastoma samples. These results suggest previously unidentified functions of Dusp26 in intracellular transport and cell-cell adhesion. Downregulation of Dusp26 may contribute to malignant phenotypes of glioma.
Introduction
Dual-specificity protein phosphatases (DSPs) form an evolutionarily conserved subgroup of protein-tyrosine phosphatases (PTPs), originally characterized by their ability to catalyse dephosphorylation of protein phospho-Ser/Thr and phospho-Tyr residues (Camps et al., 2000; Alonso et al., 2004; Pulido and Hooft van Huijsduijnen, 2008) . Dusp26 (also referred to as LDP-4, MKP-8 and NEAP) is a recently identified DSP protein and its function remains obscure. Expression of Dusp26 mRNA appears restricted to specific tissues such as brain and retina (Wang et al., 2006; Takagaki et al., 2007) . The only functional motif identified thus far in Dusp26 is a DSP catalytic domain: Dusp26 does not resemble DSP molecules belonging to the MKP family, which exhibit Rhodanase domains that recognize substrate mitogen-activated protein kinases (MAPKs: Erk, JNK and p38) (Camps et al., 2000) . To date, reports regarding Dusp26 function have been limited to its function in the MAPK pathway. Specifically, Dusp26 has been reported to function as a p38-specific phosphatase (Vasudevan et al., 2005; Yu et al., 2007) and an Erk-phosphatase (Hu and Mivechi, 2006) . In contrast, Wang et al. (2006) suggested that Dusp26 is not an MAPK phosphatase but rather negatively regulates the PI3K-Akt pathway by an unknown mechanism. In addition, Takagaki et al. (2007) reported that Dusp26 can potentiate JNK and p38 activation rather than inactivate it in a certain cellular contexts. Thus, the regulatory functions of Dusp26 on MAPK function are controversial. On the basis of these findings, we hypothesized that Dusp26 might interact with unidentified cofactor(s) and/or substrate(s), in addition to proteins in the MAPK cascade.
The KIF3 complex, a microtubule plus-end-directed motor and member of the kinesin superfamily (KIF), functions in transport of membrane organelles and is composed of two motor subunits, Kif3a and Kif3b, and a nonmotor subunit Kap3 (Hirokawa, 2000b) . Mice lacking either Kap3 or Kif3a show loss of left-right asymmetry and embryonic lethality due to the proteins' indispensable function in formation of primary cilia and nodal flow during embryogenesis (Takeda et al., 1999; Hirokawa, 2000a; Hirokawa et al., 2006) . The KIF3 motor is also implicated in tumorigenesis: cancer-related proteins such as adenomatous polyposis coli (APC), b-catenin-cadherin(s) and the Par3 polarity complex have been identified as KIF3-cargos (Jimbo et al., 2002; Nishimura et al., 2004) . b-catenin and cadherin associate with the KIF3 motor probably through interaction of b-catenin with Kap3 (Jimbo et al., 2002) . Conditional Kap3 knockout mice develop neuroepitherial tumors likely due to defects in post-Golgi transport of the b-catenin/N-cadherin complex to the cell periphery, resulting in abnormal b-catenin accumulation in the cytosol and nucleus (Teng et al., 2005) . More recently, an important function for KIF3 in regulating b-catenindependent gene expression in response to Wnt signaling by cilia-dependent mechanism has been reported (Corbit et al., 2008) .
b-catenin/cadherin(s) subcellular localization is critical for tumorigenesis. Cadherin(s) at the plasma membrane functions in calcium-dependent cell-cell interactions whereas b-catenin links cell adhesion to activities of the actin cytoskeleton. Recent studies reveal that modulation of cell-cell contact affects cell motility and has consequences for cancer metastasis. Furthermore, defects in transport of b-catenin/cadherin(s) to the cell periphery result in aberrant accumulation of b-catenin in the cytosol as well as in the nucleus, where it together with T-cell factor (TCF) functions as a transcriptional mediator of canonical Wnt signaling. Thus proper localization of the b-catenin-cadherin complex at cellcell junctions is essential for tumor suppression.
Here, using yeast two-hybrid screening, we identified Kif3a, a subunit of the KIF3 microtubule-dependent protein motor, as a Dusp26-interacting protein (Figure 1 ). We also demonstrate that Dusp26 dephosphorylates the Kap3 subunit of the KIF3 motor and enhances N-cadherin-mediated cell-cell interactions. Finally we analyse tumor samples and show that Dusp26 expression is downregulated in gliomas, suggesting it may have a tumor-suppressive function in brain tumors.
Results

Dusp26 interacts with the KIF3 kinesin motor
To search for factors interacting with Dusp26 we undertook yeast two-hybrid screening of a human embryonic brain cDNA library. One of the clones obtained encoded the Kif3a C terminus (Figure 1a) . We did not detect interaction between Kif3a and Dusp25, another DSP molecule showing 24% amino-acid sequence homology with Dusp26 ( Figure 1b) (Figure 1c ). Dusp26 showed cytoplasmic localization and enrichment in Golgi apparatus, as reported previously (Takagaki et al., 2007) , and strong colocalization of Dusp26 and Kif3a was observed ( Figure 1d ). We next asked whether Dusp26 associates with Kap3, another subunit of the KIF3 motor complex. As shown in Figure 2a , Kap3, as well as Kif3a, was also efficiently co-immunoprecipitated with Dusp26. In a yeast two-hybrid assay, interaction between Dusp26 and Kap3 was relatively weak when compared to that of Dusp26-Kif3a (Figure 2b ). Collectively, these results suggest that Dusp26 binds to the KIF3 motor complex, primarily through interaction with the Kif3a subunit.
Dephosphorylation of Kap3 by Dusp26
It has been reported that Kap3 is a phosphoprotein, and that its phosphorylation is regulated during cell cycle (Haraguchi et al., 2006) . To elucidate the significance of the Dusp26-KIF3 motor interaction, we asked whether Kap3 was a Dusp26 substrate. To this end, we analysed Kap3 phosphorylation using a recently developed phosphate-binding tag (Phos-tag) that captures phosphomonoester dianions bound to Ser, Thr and Tyr residues (Kinoshita et al., 2006) . As shown in Figure 3a Regulation of KIF3 and cell-cell adhesion by Dusp26 N Tanuma et al demecolcine, a microtubule-disrupting reagent ( Figure 3c ). These findings are consistent with a previous report that Kap3 phosphorylation increases as cells progress toward M-phase (Haraguchi et al., 2006) . Strikingly, coexpression of Dusp26 markedly decreased Kap3 phosphorylation, whereas an inactive Dusp26 mutant, Dusp26-CS, had no effect on Kap3 phosphorylation levels (Figure 3d ).
To characterize Dusp26-mediated dephosphorylation of Kap3, we constructed several N-terminally truncated mutants of Dusp26 (Figure 4a ). Dusp26-DN15 and DN36 suppressed Kap3 phosphorylation as well as did full-length Dusp26. By contrast, expression of Dusp26-DN58 did not decrease Kap3 phosphorylation (Figure 4b ), indicating that the Dusp26 N terminus is essential for mediating Kap3 dephosphorylation. Notably, this region is also required for co-immunoprecipitation of Kif3a and Kap3 with Dusp26. As shown in Figure 4c , deletion of the N terminus by 36 or 58 but not 15 amino acids produced gradual decreases in Dusp26/ Kif3a and Dusp26/Kap3 co-immunoprecipitations, suggesting that the entire Dusp26 N terminus contributes to the Dusp26/KIF3 interaction. Although the Dusp26 N terminus is required for Kap3 dephosphorylation and Dusp26/KIF3 association together with Figure 3b , we could not exclude the possible structural functions of this region (see below). The interaction between Dusp26 and KIF3 motor at endogenous levels was confirmed by co-immunoprecipitation of Kif3a with Dusp26 from lysate of IMR-32 neuroblastoma cells (Figure 4d ). In addition, we also observed co-immunoprecipitation of N-cadherin and b-catenin with Dusp26 (see below). To determine whether Dusp26 dephosphorylates Kap3 directly, we prepared recombinant Dusp26 proteins but found that GST-Dusp26 (full length) expressed in Escherichia coli and His-Dusp26 translated in vitro using wheat germ extracts were highly insoluble, preventing analysis using these proteins. Thus we performed in vitro experiments using recombinant Dusp26-DN15 protein.
Purified GST-Dusp26-DN15 showed vanadate-sensitive catalytic activities against a pNPP substrate in agreement with general features of PTP and DSP enzymes (Figure 4e ). Incubation of cell lysate containing Kap3 with GST-Dusp26-DN15 in vitro under dephosphorylation conditions, that is, in the absence of phosphatase inhibitors, resulted in loss of phosphorylated Kap3 in a vanadate-sensitive manner (Figure 4f ). In addition, purified Kap3 was also dephosphorylated by GST-Dusp26-DN15 in vitro, indicating that Kap3 is a Dusp26 substrate (Figure 4g ).
In the course of this study, we found that Dusp26 can be translated from an alternative start site. Dusp26 mRNA including its 5 0 -untranslated region appeared to be translated mainly from a second or third in-fame ATG codon (Met11 or Met14) (Tanuma et al., unpublished observations). Thus we excluded full-length Dusp26 from further analysis. Note that Dusp26-DN15 showed characteristics similar to full-length protein in terms of association with KIF3 and Kap3 dephosphorylation as described previously but slightly different localization from full-length protein (that is, mild enrichment in the Golgi apparatus, as shown in Figure 6 ).
Dusp26 enhances N-cadherin-mediated cell-cell contacts
To analyse consequences of Dusp26-mediated Kap3 dephosphorylation, stable cell lines expressing Dusp26 (DN15) or its inactive mutant (DN15CS) were developed by retroviral infection of NIH3T3 cells (Figure 5a) . Expression of endogenous Dusp26 in parent NIH3T3 cells was under the detection limit by western blot and immunohistochemical analysis (see below). After drug selection, pools of cells were analysed to avoid clonal variation. As KIF3 was implicated in intracellular transport of N-cadherin, aggregation assays were performed to examine the effect of Dusp26 on cell-cell adhesion. As shown in Figures 5b and c, NIH3T3 cells expressing Dusp26-DN15 (NIH3T3-DN15) showed more rapid aggregate formation than did cells infected with vector only (NIH3T3-vector) or with Dusp26-DN15CS (NIH3T3-DN15CS). Increased adhesiveness of NIH3T3-DN15 cells was lost when Ca 2 þ -dependent adhesion was blocked by EGTA, suggesting that Dusp26 specifically enhances Ca 2 þ -dependent cell adhesion (Figure 5b ). Western blotting of lysates from stable lines indicated little change in total N-cadherin levels in these cells (Figure 5a ). Immunostaining revealed that N-cadherin was localized to the cytoplasm, to cell-cell contact sites, to the ruffling membrane and to tips of membrane protrusions in NIH3T3-vector and NIH3T3-DN15 cells seeded at subconfluent densities (Figure 6a ). In these conditions, colocalization of N-cadherin and Dusp26-DN15 was observed at the membrane ruffle but not at cell-cell contact sites. When cells were cultivated at higher density to allow cell-cell contacts, N-cadherin was concentrated at contact sites in NIH3T3-vector cells (Figure 6b ). Strikingly, accumulation of N-cadherin at the cell periphery was much more pronounced in NIH3T3-DN15 cells and correlated with virtual loss of cytosolic N-cadherin, in contrast to NIH3T3-vector and NIH3T3-DN15CS cells. Similar results were obtained when cells were stained for b-catenin (Figure 6c) . Overall, these results suggest that Dusp26 promotes N-cadherin-mediated cell-cell adhesion. We also generated cells expressing Dusp26-DN58 mutant. Neither cell adhesiveness nor N-cadherin/bcatenin localization was affected by the Dusp26-DN58 but its expression was low (Supplementary Figure 1a and data not shown). This was probably due to its misfolding of the mutant protein since recombinant GST-Dusp26-DN58 showed little pNPPase activity (Supplementary Figure 1b) . Thus it remains not clear whether the Dusp26 N-terminal region is directly involved in association with Kif3a/Kap3 while it is required for mediating both Kap3 dephosphorylation and increased cell adhesiveness.
Downregulation of Dusp26 expression in human brain tumors Previous studies revealed preferential Dusp26 expression in brain and that Dusp26 mRNA is broadly
Regulation of KIF3 and cell-cell adhesion by Dusp26 N Tanuma et al expressed in neuronal and glial populations throughout the brain, except in hippocampus (Takagaki et al., 2007) . We undertook qRT-PCR analysis of human glioblastoma samples and found that Dusp26 mRNA was downregulated in eight of nine patients evaluated (Figure 7a ). Together with findings that cell-cell adhesion is enhanced in cells expressing Dusp26, these results suggest tumor-suppressing activities of Dusp26 and raise the possibility that the extent of Dusp26 downregulation correlates with invasive phenotypes of glioblastomas.
Discussion
Cadherin-mediated cell-cell adhesion plays pivotal functions for regulation of cell proliferation, differentiation and polarity, and overall has significant effect on In vitro dephosphorylation reactions were performed as described in 'Materials and methods', and analysed for Kap3 phosphorylation by Phos-tag/SDS-PAGE followed by western blotting. Severe distortion of the bands, seen in repeated experiments, was likely due to vanadate acting as pseudo-phosphate, and thereby disturbed Phos-tag/protein interactions. (g) Dephosphorylation experiments were performed, as in (f), using immunopurified Kap3.
Regulation of KIF3 and cell-cell adhesion by Dusp26 N Tanuma et al tissue architecture. Altered adhesiveness is often associated with increased cell motility, invasiveness and tumor metastasis. We have shown that Dusp26 dephosphorylates the Kap3 subunit of the KIF3 motor and promotes localization of N-cadherin/b-catenin to sites of cell-cell contact, resulting in enhanced adhesion. Regulation of KIF3 and cell-cell adhesion by Dusp26 N Tanuma et al
It has been established that post-Golgi transport of b-catenin/Cadherin(s) to the plasma membrane is mediated by the KIF3 motor (Jimbo et al., 2002; Teng et al., 2005) . Although the detailed mechanisms by which Dusp26 enhances distribution of N-cadherin/ b-catenin remain unclear, they likely involve Kap3 dephosphorylation by Dusp26, since expression of its inactive mutant does not alter Ca 2 þ -dependent adhesion ( Figure 5 ) or N-cadherin localization (data not shown). Accumulated evidence reveals the importance of molecular motors such as myosin, dynein and KIF proteins in organelle transport, but it remains largely unknown how binding and release of cargo at destination sites are regulated. Our results suggest a possible function for Kap3 phosphorylation in these processes. Previous studies in which phosphorylation of the myosin-V and KIF17 motors by calcium/calmodulin-dependent protein kinase II were suggested to control docking of cargo (Karcher et al., 2001; Guillaud et al., 2008) support our hypothesis. Identification of Kap3 phosphorylation site(s) is the next critical step to address these issues.
Analysis of human glioblastoma revealed that Dusp26 expression was low compared to that seen in normal brain in most samples. Given that cell-cell adhesion was enhanced in cells expressing Dusp26, these results suggest tumor-suppressing activities of Dusp26, and that Dusp26 gene is silenced and/or deactivated in glioma. Dusp26 downregulation may be associated with invasive phenotypes of glioblastomas, although mechanisms underlying Dusp26 downregulation are not known.
In summary, Dusp26 dephosphorylates Kap3, enhances cell-cell adhesion by promoting localization of N-cadherin/b-catenin at sites of cell-cell contact and is downregulated in human glioblastomas. Further investigation to elucidate mechanisms regulating Dusp26 expression in brain tumors and identify kinase(s) responsible for Kap3 phosphorylation is required to understand how dysregulation of intracellular transport and cell-cell adhesion coincides with tumor development.
Materials and methods
Antibodies
Anti-Flag M2 and anti-Myc 9E10 antibody were purchased from Sigma (St Louis, MO, USA) and Roche (Basel, Switzerland), respectively. Anti-b-Catenin (#14), anti-NCadherin (#32), anti-Kap3 (#14) and anti-Kif3a (#28) monoclonal antibodies were from BD Transduction (San Jose, CA, USA). Polyclonal anti-Dusp26 antibodies were described previously (Takagaki et al., 2007) .
Yeast two-hybrid screening Full-length cDNA encoding human Dusp26 was subcloned into pBTM116-HA and used as bait to screen a human fetal brain cDNA library subcloned into pACT II (Clontech Laboratories Inc., Mountain View, CA, USA). The L40 yeast strain was transformed with bait and library plasmids, and about 3 Â 10 6 clones were screened. A total of 22 positive clones were obtained and sequenced.
Cell culture, transfection and retrovirus infection HeLa-TetOff (Clontech) and COS-7 cells were transfected using Fugene6 (Roche, Mannheim, Germany) reagent following the manufacturer's recommendation. Dusp26 expression plasmids were described previously (Takagaki et al., 2007) . Human Kif3a and Kap3 cDNAs were subcloned into pCMVMyc (Clontech). For stable transfection, Flag-tagged Dusp26 cDNAs were subcloned into the retroviral vector pMXs-puro. The packaging line (PLAT-E cells; Morita et al., 2000) was grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS) and transfected with a series of pMXs-puro-Dusp26 plasmids using Fugene 6. The medium was changed the next day and further cultured for 1 day. Supernatants were used to infect NIH3T3 cells in the presence of polybrene at 7.5 mg/ml for 5 h. Infectants were selected and maintained in medium plus puromycin. Human ATC cell lines 8305C, 8505C and HTC/C3 were obtained from the Health Science Research Resources Bank (Ibaraki, Japan). 8505C and HTC/C3 cells were cultured in DMEM with 10% FCS. 8305C cells were maintained using MEM with 10% FCS. The human IMR-32 neuroblastoma line was from RIKEN Bioresource Center (Tsukuba, Japan) and cultured in MEM supplemented with nonessential amino acids (Gibco, Carlsbad, CA, USA) and 10% FCS.
Western blot analysis
Immunoprecipitation and western blotting were performed as described (Takagaki et al., 2007) . To analyse Kap3 phosphorylation, cells were washed in Hepes buffer twice, harvested and lysed in radioimmunoprecipitation assay buffer by sonication using Bio-ruptor (CosmoBio, Tokyo, Japan). Samples were separated on a 6% SDS-polyacrylamide gel, with 50 mM Phos-tag acrylamide (ALL-107) and 100 mM MnCl 2 . Gels were soaked in transfer buffer with 5 mM EDTA for 10 min and electrotransferred. Regulation of KIF3 and cell-cell adhesion by Dusp26 N Tanuma et al Immunohistochemistry Cells were seeded on collagen-coated coverslips in 12-well plates at 2.5 Â 10 4 cells per well (subconfluent condition) and fixed on the next day. To obtain confluent monolayers, cells were seeded at 2 Â 10 5 cells per well, cultured for 2 days and fixed. Immunostaining was performed as described (Takagaki et al., 2007) except images were obtained using a Pascal confocal laser-scanning microscope (Zeiss, Jena, Germany). DRAQ5, a fluorescent DNA probe was obtained from Alexis (Lausen, Switzerland).
Phosphatase assay and dephosphorylation of Kap3 in vitro GST-Dusp26-DN15 was expressed in the E. coli DH5a strain using the pGEX system (GE Healthcare UK Ltd., Buckinghamshire, UK) and purified using glutathione sepharose 4B following the manufacturer's recommendations. pNPPase assays were performed as described previously (Takagaki et al., 2007) . For in vitro Kap3 dephosphorylation experiments, Kap3 was prepared by sonication of cells transfected with Myc-Kap3 in buffer (50 mM Tris-Cl, 150 mM NaCl, 10% glycerol, 0.1% Triton X-100). Cleared lysates were supplemented with dithiothreitol (DTT) at 5 mM and incubated with or without GST-Dusp26-DN15 at 30 1C for 3 h in the presence or absence of 1 mM vanadate. In Figure 4g , Myc-Kap3 was immunopurified from cells transfected Myc-Kap3 using antiMyc-Agarose (Sigma).
Cell aggregation assays
Cells were trypsinized in phosphate-buffered saline supplemented with 2 mM CaCl 2 , suspended in medium, washed with and then resuspended in medium, passed through a 27 G needle three times, and adjusted to 5 Â 10 5 cells per ml. Cells were incubated in 1.5 ml tubes with gentle rotation at 37 1C to allow aggregate formation. After 20 min, aliquots of the suspension were evaluated and the extent of aggregation calculated by the index (N 0 -N 20 )/N 0 , where N 20 is the total particle number after 20 min incubation and N 0 is the total particle number at the initiation of incubation, as described previously (Ozawa et al., 1990) . One-way analysis of variance combined with Tukey's test was used to analyse data with unequal variance between each group. A probability level of 0.05 was considered significant.
Primary tumor samples, qRT-PCR
Human glioblastoma samples were obtained with informed consent from nine patients at the time of surgical removal at the Division of Neurosurgery, Miyagi Cancer Center. Histological diagnoses were based on WHO (World Health Organization) criteria by a neuropathologist. RNA analyses were approved by the institutional review of Miyagi Cancer Center. RNAs were prepared using Isogen (Nippon Gene, Tokyo, Japan) reagent and reverse-transcribed using oligo-dT primer and Superscript III RTase (Invitrogen, Carlsbad, CA, USA). Relative amounts of Dusp26 cDNA were quantified using the LightCycler 480, a LightCycler 480 probes master kit, TaqMan probe no. 79 from the universal probe library (Roche), and the Dusp26-specific primers (sense) 5 0 -GCTGCCGACTT CATCCAC-3 0 and (antisense) 5 0 -CAGCACAATGCACCAG GAT-3 0 . Relative amounts of porphobilinogen deaminase (PBGD) mRNA was simultaneously estimated similarly using TaqMan probe no. 25 and specific primers (sense) 5 0 -AGCTATGAAGGATGGGCAAC-3 0 and (antisense) 5 0 -TTGTATGCTATCTGAGCCGTCTA-3 0 . Human brain (frontal lobe) total RNAs from a pool of four different donors and from single donor were obtained from Clontech and BioChain Institute (Hayward, CA, USA), respectively.
